About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3029314
Allelic
Composition
Slc34a1tm1Hten/Slc34a1tm1Hten
Genetic
Background
involves: 129S2/SvPas * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Slc34a1tm1Hten mutation (1 available); any Slc34a1 mutation (3 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Histological appearance of bone from wild-type, Slc34a1tm1Hten/Slc34a1+ and Slc34a1tm1Hten/Slc34a1tm1Hten mice

mortality/aging
• 44% of homozygotes die before or at weaning (J:47637)
• death is attributed to poor nutritional status (J:47637)
• homozygotes that survive weaning appear normal thereafter, despite smaller size and lower body weight (J:47637)
• 44% of homozygotes die before or at weaning (J:47637)
• death is attributed to poor nutritional status (J:47637)
• homozygotes that survive weaning appear normal thereafter, despite smaller size and lower body weight (J:47637)

behavior/neurological
• homozygotes frequently have difficulties in feeding during the first 2 weeks of life (J:47637)
• homozygotes frequently have difficulties in feeding during the first 2 weeks of life (J:47637)
• homozygotes display some lethargy during the first 2 weeks of life (J:47637)
• homozygotes display some lethargy during the first 2 weeks of life (J:47637)

growth/size/body
• at birth, homozygotes are noticeably smaller than wild-type littermates (J:47637)
• at birth, homozygotes are noticeably smaller than wild-type littermates (J:47637)
• at birth, homozygotes exhibit a significantly reduced body weight relative to wild-type controls (1.49 0.08 g vs 1.89 0.12 g) (J:47637)
• at birth, homozygotes exhibit a significantly reduced body weight relative to wild-type controls (1.49 0.08 g vs 1.89 0.12 g) (J:47637)
• homozygotes remain significantly smaller than wild-type littermates for at least 4 months after birth (J:47637)
• homozygotes remain significantly smaller than wild-type littermates for at least 4 months after birth (J:47637)
• homozygotes maintain a significantly lower body weight for at least 4 months after birth (J:47637)
• homozygotes maintain a significantly lower body weight for at least 4 months after birth (J:47637)

homeostasis/metabolism
• at 2-3 months of age, serum PTH levels are appropriately decreased in response to hypercalciuria (J:47637)
• at 2-3 months of age, serum PTH levels are appropriately decreased in response to hypercalciuria (J:47637)
• serum calcium levels are slightly but significantly increased at all ages examined, in an age-independent manner (J:47637)
• serum calcium levels are slightly but significantly increased at all ages examined, in an age-independent manner (J:47637)
• at 1-7 months of age, serum inorganic phosphate (Pi) levels are significantly reduced (J:47637)
• at 1-7 months of age, serum inorganic phosphate (Pi) levels are significantly reduced (J:47637)
• young homozygotes display significantly higher serum ALPase activity relative to age-matched wild-type and heterozygous mice (J:47637)
• however, by 4 months of age, serum ALPase activity is comparable in all three genotypes (J:47637)
• young homozygotes display significantly higher serum ALPase activity relative to age-matched wild-type and heterozygous mice (J:47637)
• however, by 4 months of age, serum ALPase activity is comparable in all three genotypes (J:47637)
• at 1-3 months of age, homozygotes exhibit an appropriate adaptive increase in serum 1,25(OH)2D levels in response to hypophosphatemia (J:47637)
• at 1-3 months of age, homozygotes exhibit an appropriate adaptive increase in serum 1,25(OH)2D levels in response to hypophosphatemia (J:47637)
• at 1 month of age, the urine calcium/creatinine ratio and the fractional excretion index for calcium (FEICa) are significantly increased (J:47637)
• at 1 month of age, the urine calcium/creatinine ratio and the fractional excretion index for calcium (FEICa) are significantly increased (J:47637)
• at 1 month of age, the urine Pi/creatinine ratio and the fractional excretion index for Pi (FEIPi) are strikingly increased (J:47637)
• at 1 month of age, the urine Pi/creatinine ratio and the fractional excretion index for Pi (FEIPi) are strikingly increased (J:47637)

renal/urinary system
N
• homozygotes show no evidence for amino aciduria, glycosuria, or proteinuria, indicating that the renal inorganic phosphate leak is not due to a generalized tubulopathy (J:47637)
• homozygotes show no evidence for amino aciduria, glycosuria, or proteinuria, indicating that the renal inorganic phosphate leak is not due to a generalized tubulopathy (J:47637)
• at 1 month of age, the urine calcium/creatinine ratio and the fractional excretion index for calcium (FEICa) are significantly increased (J:47637)
• at 1 month of age, the urine calcium/creatinine ratio and the fractional excretion index for calcium (FEICa) are significantly increased (J:47637)
• at 1 month of age, the urine Pi/creatinine ratio and the fractional excretion index for Pi (FEIPi) are strikingly increased (J:47637)
• at 1 month of age, the urine Pi/creatinine ratio and the fractional excretion index for Pi (FEIPi) are strikingly increased (J:47637)

skeleton
N
• homozygotes do not exhibit rickets or osteomalacia (J:47637)
• homozygotes do not exhibit rickets or osteomalacia (J:47637)
• poor initial development of cancellous bone (J:47637)
• by 45 days of age, the number metaphyseal trabeculae exceeded that in wild-type (J:47637)
• poor initial development of cancellous bone (J:47637)
• by 45 days of age, the number metaphyseal trabeculae exceeded that in wild-type (J:47637)
• initial impairment of secondary ossification in the epiphysis observed at 21 days of age (J:47637)
• by 45 days of age, the skeletal phenotype had reversed and overcompensated (J:47637)
• initial impairment of secondary ossification in the epiphysis observed at 21 days of age (J:47637)
• by 45 days of age, the skeletal phenotype had reversed and overcompensated (J:47637)

muscle
• homozygotes display apparent muscle weakness during the first 2 weeks of life (J:47637)
• homozygotes display apparent muscle weakness during the first 2 weeks of life (J:47637)

reproductive system
• homozygotes display reduced reproductive ability relative to wild-type and heterozygous controls (J:47637)
• homozygotes display reduced reproductive ability relative to wild-type and heterozygous controls (J:47637)


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Tumor Biology (MTB), Gene Ontology (GO), MouseCyc
Citing These Resources
Funding Information
Warranty Disclaimer & Copyright Notice
Send questions and comments to User Support.
last database update
02/02/2016
MGI 6.02
The Jackson Laboratory